Ex Vivo Lung Perfusion Consensus - European & American Perspectives Presented by Lung Bioengineering скачать в хорошем качестве

Ex Vivo Lung Perfusion Consensus - European & American Perspectives Presented by Lung Bioengineering

ISHLTv Industry Webinar: Ex Vivo Lung Perfusion Consensus - European and American Perspectives, presented by Lung Bioengineering (17 June, 2025) Ex vivo lung perfusion (EVLP) has emerged as a transformative technique in lung transplantation, offering new possibilities for organ preservation and assessment. Despite its success, transplant centers worldwide face critical decisions in determining which lungs are suitable for EVLP. This webinar brings together leading experts from Europe and the US to discuss two pivotal consensus documents that guide these decisions. This webinar explores the differences between the European and American approaches on selecting allografts for EVLP and the implications for resource utilization and clinical outcomes. Presentations: Introduction Pedro Catarino, MD, Cedars-Sinai, Los Angeles, CA USA European Society of Organ Transplantation (ESOT) Consensus Statement on Machine Perfusion in Cardiothoracic Transplant Marius Berman, MD, FRCS (CTh), Royal Papworth Hospital, Cambridge, UK North American Expert Consensus on the Clinical Role of Ex Vivo Lung Perfusion (EVLP) With Acellular Perfusate Matthew Bacchetta, MD, Vanderbilt University Medical Center, Nashville, TN USA Discussion evaluating the differences between the two publications Kenneth McCurry, MD, Cleveland Clinic, Cleveland, OH USA Panel Discussion with all speakers